The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
Status:
Recruiting
Trial end date:
2025-07-15
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of teriflunomide plus danazol versus danazol in patients
with steroid-resistant/relapse ITP
Phase:
Phase 2
Details
Lead Sponsor:
Peking University People's Hospital
Collaborators:
Beijing Friendship Hospital Beijing Hospital Beijing Luhe Hospital Beijing Tsinghua Changgeng Hospital China-Japan Friendship Hospital Chinese PLA General Hospital Navy General Hospital, Beijing Peking University First Hospital Peking University Third Hospital